توپيرامات تيڤع ١٠٠ ملغ إسرائيل - العربية - Ministry of Health

توپيرامات تيڤع ١٠٠ ملغ

teva pharmaceutical indust.ltd - topiramate 100 mg - tablets - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

توپيرامات تيڤع ٢٠٠ ملغ إسرائيل - العربية - Ministry of Health

توپيرامات تيڤع ٢٠٠ ملغ

teva pharmaceutical indust.ltd - topiramate 200 mg - tablets - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

ىاسمىن إسرائيل - العربية - Ministry of Health

ىاسمىن

bayer israel ltd - drospirenone 3 mg; ethinylestradiol 0.03 mg - film coated tablets - drospirenone and estrogen - oral contraception.

ىاز إسرائيل - العربية - Ministry of Health

ىاز

bayer israel ltd - drospirenone 3 mg; ethinylestradiol 0.02 mg - film coated tablets - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).